NASDAQ:NTRABiotechnology / BiotechnologyDelayed public snapshot

Natera Inc

A read-only Alphactor snapshot for Natera Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.

Snapshot as of 2026-04-17

Topline snapshot

Latest Close

$208.4

30-Day Move

-11.5%

Market Cap

$28.0B

Shares Outstanding

141,730,000

P/B Ratio

18.5

ROE

-12.2%

Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot

$208.40

-11.5%last 90 delayed daily bars

Market cap $28.0B

90D High

$256.36

90D Low

$181.00

Avg Volume

1,204,701

What stands out

Gross margin is running at 64.8%, which gives a quick read on operating quality before you open the full model.

Net margin is -9.0%, useful for comparing NTRA against peers in Biotechnology.

NTRA is down 11.5% over the last 30 trading days shown on this page.

Latest operating income is $-23M, which helps anchor the headline ratios with an actual earnings figure.

Research snapshot

Composite Fair Value

$39.04

Rule of 40

60.2%

Fundamentals snapshot

Latest Close

$208.4

30-Day Move

-11.5%

Market Cap

$28.0B

Shares Outstanding

141,730,000

P/B Ratio

18.5

ROE

-12.2%

ROA

-8.7%

Gross Margin

64.8%

Operating Margin

-13.4%

Net Margin

-9.0%

Debt / Equity

0.05

Current Ratio

3.39

Latest Revenue

$665M

Financial statement snapshot

Revenue

$665M

Gross Profit

$445M

Operating Income

$-23M

Net Income

$47M

Gross Margin

6475.0%

Net Margin

-903.0%

Current Ratio

3.39

Debt / Equity

0.05

Valuation snapshot

Fair Value

$39.04

Upside / Downside

-81.3%

Signal

Overvalued

Implied Growth

48.8%

DCF

$12.87

EV/Rev

$65.22

Growth Assumption

5.0%

Discount Rate

8.4%

Terminal Growth

2.0%

Base FCF

$59M

Valuation spread

Current Price
$208.40
Composite Fair Value
$39.04
DCF
$12.87
EV/Rev
$65.22

After signup

The full valuation workspace goes deeper

Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.

Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.

Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.

Sign up to open the valuation workspace

Very aggressive growth priced in

Quality snapshot

Altman Z

35.23

Safe

Piotroski

6

Moderate (4-6)

Cash Conversion

-0.71x

Rule of 40

60.2%

Elite

Annual financial history

Annual performance mix

PeriodRevenueOperating IncomeNet IncomeFree Cash Flow
2021-12-31--------
2022-12-31$820M$-541M$-548M$-479M
2023-12-31$1.1B$-446M$-435M$-286M
2024-12-31$1.7B$-222M$-190M$59M

After signup

The app opens the full statement deep dive

Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.

Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.

Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.

Sign up to open the full statements
Institutional holders snapshot

Vanguard Group

Filed 2026-01-29

$2.8B

-0.7%

Farallon Capital

Filed 2026-02-17

$897M

-8.0%

BlackRock

Filed 2024-08-13

$733M

--

Coatue Management

Filed 2026-02-17

$603M

+1446.1%

Geode Capital Management

Filed 2026-02-09

$596M

+0.5%

Premium previews

See where the deeper analysis goes next

Sign up free
Open a preview card to sample a premium module.

High-intent actions

What you can do after signup

Organic traffic stays on the free tier by default, but signing up lets you save work and continue exploring.

For informational and educational purposes only. Not financial advice. Learn more

For informational and educational purposes only. Not financial advice. Learn more